Tracks more than 150 upcoming facilities established since 2020 and over 150 recently founded emerging biotech companies founded since 2017. It’s a 2-in 1 tracker that brings unique data on emerging biopharma facilities and companies that are gaining a lot of traction in the biopharma industry. The data and companies included in this tracker is covered across 11 APAC countries including China, South-Korea, Japan, India, South-East Asia countries, Taiwan and Australia among others.
APAC Emerging Biopharma Data showcases the key information on emerging biologics manufacturing facilities and companies based on over 50 metrics including biologics products in development, list of technology/service partners, investors, upstream and downstream processing technologies, regulatory compliance followed by facilities, ongoing and completed projects, platform technology, company plans and updates, funding details, USP of company and partnership requirements and many other parameters. The complete list of parameters for both emerging facilities and companies’ information are mentioned in further section.
The data is underpinned by user-friendly visuals to allow users to filter through data by emerging company, manufacturing facility specialisation, company establishment year, product type, scale of operation, expression system and other filters.